Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA2884 TegaserodSummary: Tegaserod is an orally effective 5-hydroxytryptamine receptor 4(;) agonist and receptor antagonist. -
BA2885 ROC-325Summary: ROC-325 is a potent orally active autophagy inhibitor with strong anticancer activity. -
BA2886 MBM-55Summary: MBM-55 is an effective inhibitor. -
BA2887 TironSummary: Tiron is a non-toxic chelator of many metals. -
BA2888 UlinastatinSummary: Ulinastatin (Uristatin) is a trypsin and serine protease inhibitor. -
BA2890 INI-43Summary: INI-43 is an inhibitor that interferes with the nuclear localization of Kpnβ1 and known Kpnβ1cargo proteins, NFAT, NFκB, AP-1 and NFY. -
BA2891 ArtemisiteneSummary: Artemisitene is a natural derivative of Artemisinin, an activator with antioxidant and anticancer activity. -
BA2892 FOXO4-DRISummary: FOXO4-DRI is a cell-permeable peptide antagonist. -
BA2893 DMU-212Summary: DMU-212 is a resveratrol methylated derivative with antidisintegrative, antiproliferative, antioxidant and apoptosis-promoting activities. -
BA2894 ARS-853Summary: ARS-853 is a selective, covalent inhibitor.

